Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/5/25 16:12 | 8/19/25 | GRAL | Health | Health | Medical Laboratories | Ofman Joshua J. | CA | O | P | 12 | S.m | -12,224 | 45.33 | 0 | -270 | 562 | D | |||||||||||||||
12/5/25 16:12 | 5/2/25 | GRAL | Health | Health | Medical Laboratories | Ragusa Robert P | CA | DO | CEO | 7 | S | -9,747 | 34.69 | 0 | -281 | 836 | D | |||||||||||||||
12/5/25 16:12 | 8/19/25 | GRAL | Health | Health | Medical Laboratories | Freidin Aaron | CA | O | CFO | 10 | S | -5,165 | 40.68 | 0 | -127 | 337 | D | |||||||||||||||
11/18/25 21:33 | 11/17/25 | GRAL | Electr | LabEq | Laboratory Analytical Instrum | Illumina, Inc. | CA | T | 1 | S | -79,850 | 79.85 | 0 | -1,000 | 3,502 | D | ||||||||||||||||
7/3/25 16:31 | 7/1/25 | GRAL | Health | Health | Medical Laboratories | Ding Chun R | CA | T | 1 | S | -16,830 | 49.53 | 0 | -340 | 3,305 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |